Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to...

Keywords

TrastuzumabMedicineChromogenic in situ hybridizationCISHCancerGene duplicationCancer researchCarcinomaBreast carcinomaHER2/neuBreast cancerPathologyInternal medicineIn situ hybridizationBiologyGeneGene expression

Affiliated Institutions

Related Publications

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Dennis J. Slamon , William Godolphin , Lovell A. Jones +8 more

Carcinoma of the breast and ovary account for one-third of all cancers occurring in women and together are responsible for approximately one-quarter of cancer-related deaths in ...

1989 Science 6787 citations

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene

Dennis J. Slamon , Gary M. Clark , Steven Wong +3 more

The HER-2/ neu oncogene is a member of the erb B-like oncogene family, and is related to, but distinct from, the epidermal growth factor receptor. This gene has been shown to be...

1987 Science 11567 citations

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

Manfred Hofmann , Oliver Stoß , Di Shi +6 more

Aims: Human epidermal growth factor receptor 2 (HER2) overexpression/amplification is implicated in the development of various solid tumour types. Validated methods and scoring ...

2008 Histopathology 1169 citations

Amplification and over-expression of the neu oncogene in human breast carcinomas.

Marc J. van de Vijver , W. J. Mooi , J.L. Peterse +1 more

Amplification of the neu (or c-erbB-2 or HER) oncogene is found to be present in 15-30% of human breast carcinomas and has been reported to correlate with poor prognosis. We bri...

1988 PubMed 31 citations

Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial

Mitch Dowsett , Marion Procter , Worta McCaskill‐Stevens +11 more

Purpose To determine whether (1) immunohistochemical (IHC) HER2 status (ie, 2+ or 3+), (2) degree of fluorescence in situ hybridization (FISH) amplification according to (2a) HE...

2009 Journal of Clinical Oncology 184 citations

Publication Info

Year: 2005
Type: article
Volume: 16
Issue: 2
Pages: 273-278
Citations: 649
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

649

OpenAlex

Cite This

APA Style

                            
                                
                                    Minna Tanner, 
                                
                                    Maija Hollmén, 
                                
                                    Teemu T. Junttila
                                
                                et al.
                            
                            (2005). 
                            Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. 
                            Annals of Oncology
                            , 16
                            (2)
                            , 273-278.
                            https://doi.org/10.1093/annonc/mdi064
                        

Identifiers

DOI: 10.1093/annonc/mdi064